ZOL inhibits prenylation of Ras [14] and accordingly Ras-mediated signaling pathways, including Erk [15] and PI3K/Akt [16] pathways, which are potentially associated with intrinsic RT resistance of tumor cells [17]. This evidence concerns the gene AKT1 and neoplasm.